๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer

โœ Scribed by P.F. Conte; M.R. Sertoli; M. Bruzzone; A. Rubagotti; R. Rosso; G. Bentivoglio; A. Conio; G. Pescetto

Book ID
119052538
Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
425 KB
Volume
20
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Paclitaxel, 5-fluorouracil, and cisplati
Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma
โœ Yeul H. Kim; Sang W. Shin; Byung S. Kim; Jin H. Kim; Jong G. Kim; Young J. Mok; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB ๐Ÿ‘ 2 views

## Background: Although the clinical efficacy of paclitaxel in the treatment of gastric carcinoma has not been clearly defined, recent reports have suggested a possible role in the treatment of upper gastrointestinal carcinomas in vitro and in vivo. in this study, the authors evaluated the efficacy

5-Fluorouracil, adriamycin, and BCNU (FA
5-Fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer
โœ Massimo Lopez; Carlo Federico Perno; Luigi Lauro; Paola Papaldo ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 406 KB

Thirty-two evaluable patients with advanced measurable gastric adenocarcinoma were treated with a combination of 5-fluorouracil, adriamycin, and BCNU (FAB). Two complete and fourteen partial responses were observed, with an overall response rate of 50%. The median duration of response was 10 months,